コンテンツにジャンプ
国立がん研究センター 中央病院

トップページ > 診療科のご案内 > 呼吸器内科 > 呼吸器内科について > 業績 > 2011年

2011年

  1. Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, Koizumi F:Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor Breast Cancer Res. 13:R66:2011
  1. Taguchi F, Kodera Y, Katanasaka Y, Yanagihara K, Tamura T, Koizumi F:Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal Invest New Drugs. 29:1198-1205:2011
  1. Takahashi T, Yamamoto N, Tamura T, Kunitoh H, Nishiwaki Y, Negoro S:Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by ONCOLOGY LETTERS. 2:1033-1040:2011
  1. Kozu Y, Tsuta K, Kohno T, Sekine I, Yoshida A, Watanabe S, Tamura T, Yokota J, Suzuki K, Asamura H, Furuta K, Tsuda H:The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung Lung Cancer. 73:45-50:2011
  1. Tanioka M, Nokihara H, Yamamoto N, Yamada Y, Yamada K, Goto Y, Fujimoto T, Sekiguchi R, Uenaka K, Callies S, Tamura T:Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid Cancer Chemother Pharmacol. 68:505-511:2011
  1. Katori N, Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, Yomota C, Kawanishi T, Nishimaki- Mogami T, Naito M, Sawada JI, Kunitoh H, Nokihara H, Sekine I, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Yamamoto N, Okuda H, Tamura T:Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer J Pharm Sci.  100:4546-4559:2011
  1. Ohyanagi F, Horai T, Sekine I, Yamamoto N, Nakagawa K, Nishio M, Senger S, Morsli N, Tamura  T:Safety  of  BLP25  Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Jpn J Clin Oncol. 41:718-722:2011
  1. Ueda Y, Shimoyama T, Murakami H, Yamamoto N, Yamada Y, Arioka H, Tamura T:Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors. Cancer Chemother Pharmacol. 67:1101-1109:2011
  1. Murakami H, Ueda Y, Shimoyama T, Yamamoto N, Yamada Y, Arioka H, Tamura  T:Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid Cancer Chemother Pharmacol. 67:1119-1128:2011
  1. Yamada K, Yamamoto N, Yamada Y, Nokihara H, Fujiwara Y, Hirata T, Koizumi F, Nishio K, Koyama N, Tamura T:Phase I Dose Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Clin Cancer Res. 17:2528-2537:2011
  1. Sato Y, Yamamoto N, Kunitoh H, Ohe Y, Minami H, Laird NM, Katori N, Saito Y, Ohnami S, Sakamoto H, Sawada JI, Saijo N, Yoshida T, Tamura T: Genome・ Wide Association Study on Overall Survival of Advanced Non・small Cell Lung Cancer Patients Treated with Carboplatin and J Thorac Oncol. 6:132-138:2011
  1. Sekine I, Kubota K, Tamura Y, Asahina H, Yamada K, Horinouchi H, Nokihara H, Yamamoto N, Tamura T: Innovator and generic cisplatin formulations: comparison of renal Cancer Sci. 102:162-165:2011
  1. Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima・Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada JI, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura  T:Genetic  polymorphisms  and haplotypes of POR encoding cytochrome P450 oxidoreductase in a Japanese Drug Metab Pharmacokinet. 26:107-116:2011
  1. Doi T, Tahara M, Yoshino T, Yamazaki K, Tamura T, Yamada Y, Yang BB, Oliner KS, Otani S, Asahi D: Tumor KRAS Status Predicts Responsiveness to Panitumumab in Japanese Patients with Metastatic Colorectal Cancer. Jpn J Clin Oncol. 41:210-216:2011
  1. Furugen M, Sekine I, Tsuta K, Horinouchi H, Nokihara H, Yamamoto N, Kubota K, Tamura T:Combination chemotherapy with carboplatin and paclitaxel for advanced thymic Jpn J Clin Oncol. 41:1013-1016:2011
  1. Yoshida H, Sekine I, Tsuta K, Horinouchi H, Nokihara H, Yamamoto N, Kubota K, Tamura T: Amrubicin monotherapy for patients with previously treated advanced large・cell neuroendocrine carcinoma of the Jpn J Clin Oncol. 41:897-901:2011
  1. Yano S, Yamada T, Takeuchi S, Tachibana K, Minami Y, Yatabe Y, Mitsudomi T, Tanaka H, Kimura T, Kudoh S, Nokihara H, Ohe Y, Yokota J, Uramoto H, Yasumoto K, Kiura K, Higashiyama M, Oda M, Saito H, Yoshida J, Kondoh K, Noguchi M:Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese J Thorac Oncol. 6:2011-2017:2011